Connect with us
Germany is not yet particularly well positioned in research and development of novel gene and cell therapies. Most studies are carried out in the USA (48%)...
Foren Method, a Madrid-based startup, is looking for $2.25 million (€2 million) to carry out its clinical trial, for the new therapeutic tool the company developed....
Biotechnology companies have many growth levers and are to be favored for their defensive qualities, in the context of the current health and economic crisis. The...
The Basque Country-based startup gets funding from the Botín Foundation, Seed Capital Bizkaia and Wa4steam to improve Fine Birth, a device to detect false signs of...
The Burgundian biotech company announced on Monday, June 15th, the success on different efficacy criteria of its lanifibranor molecule to treat patients suffering from Non-Alcoholic Steatohepatitis,...
The company MSD is acquiring a 100% stake in Themis Bioscience through its European subsidiary. The aws Gründerfonds, which has held a stake in Themis since...
EPFL spin-off GliaPharm announced a $1.55 million (CHF 1.5 million) fund raising from the American company Gliaven LLC, bringing the total amount raised by the biotech...
Sartorius has just completed the acquisition of selected life science businesses from Danaher Corporation, for which it paid $825 million. With the acquisition of Danaher, Sartorius...
Walloon companies have shown reactivity in the corona crisis, thanks to the structuring of the biopharma ecosystem and medical equipment. A sector that could take advantage...
Remembrane develops custom lipid supplements that improve the performance of cell cultures. The company started the crowdfunding campaign on February 28th with the aim to collect...
